arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

ASP Isotopes Inc.

ASPI

$1.71 ▼ -0.21 (-10.70%) at close

5 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Moderately Bearish

auto_awesome

Analytical Summary

ASP Isotopes Inc. faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $142.0M

Dividend Yield —

Revenue Growth 475.5% ↘

Op. Margin -251.2%

ROIC -27.5% ↗

FCF / Share $-0.57 ↘

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity 0.07

info Valuation on last close. End-of-day price, Nov 5, 2026.

5-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$23.85M

↑ +475.5% —

Net Income Profit after all expenses

$-159.84M

↓ -393.0% —

FCF / Share Free cash flow per share

$-0.57

↓ -20.6% —

Long-Term Debt Long-term obligations

$14.36M

↑ +503.2% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability

Returns ↓

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue Growth YoY (%)	475.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9410%)	857.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+17040%)	—	—	—
EPS Growth YoY (%)	-234.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-28.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-172.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	-393.0% Weak ↓ Weak Declining Year-over-year change in net income	-99.0% Weak Weak Year-over-year change in net income	-229.5% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	-20.6% Weak Weak Year-over-year change in free cash flow	-102.3% Weak Weak Year-over-year change in free cash flow	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Operating Margin (%) (%)	-251.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1775%)	—	—	—	—
Effective Tax Rate (%) (%)	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.3% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF Margin (%) (%)	-198.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	0.30x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.50x Good Good Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Return on Invested Capital (%)	-27.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-52.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-98.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-51.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-12.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-40.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-78.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-752%)	-67.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-664%)	-100.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-933%)	-50.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-520%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Debt to Equity (x)	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	—	—	—
Interest Coverage (x)	-6388.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1474.60x Weak Weak Operating income divided by interest expense Optimal: > 5x	-7132.95x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-271.24M	$2.38M	—	—	—
Debt / EBITDA (x)	-0.25x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.09x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Revenue per Share (USD)	$0.29	$0.07	$0.01	—	—
Basic EPS, GAAP (USD)	$-2.11	$-0.63	$-0.49	$-0.18	—
Free Cash Flow per Share (USD)	$-0.57	$-0.47	$-0.23	—	—
Book Value per Share (USD)	$1.83	$0.66	$0.33	$0.27	$0.00
Tangible Book Value per Share (USD)	$1.75	$0.62	$0.27	$0.27	$0.00
Basic Weighted Avg Shares (shares)	83.01M	55.67M	33.07M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Working Capital (USD)	$367.22M	$58.69M	$4.84M	$1.37M	$2.92M
LT Debt (USD)	$14.36M	$2.38M	—	—	—
Total Equity (USD)	$204.15M	$47.90M	$16.30M	$9.82M	$0.00

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	$23.85M	$4.14M	$433.03K	$0.00	—
Depreciation Expense (USD)	$1.91M	$471.00K	$37.43K	$0.00	—
Net Income, GAAP (USD)	$-159.84M	$-32.42M	$-16.29M	$-4.95M	—
Operating Cash Flow (USD)	$-37.78M	$-16.70M	$-5.41M	$-2.94M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 5 years · 20 quarters

ASP Isotopes Inc.

Analytical Summary

5-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ASPI with peers